Redmond Asset Management, LLC Precigen, Inc. Transaction History

Redmond Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 04, 2022	BUY	$3.53 - $5.5 $960 - $1,496	272 Added 2.38%	11,689 $43,000
Q4 2020 Feb 11, 2021	BUY	$3.75 - $10.56 $937 - $2,640	250 Added 2.24%	11,417 $116,000
Q2 2020 Aug 10, 2020	SELL	$2.16 - $5.46 $140 - $354	-65 Reduced 0.58%	11,167 $56,000
Q1 2020 May 06, 2020	BUY	$1.46 - $7.19 $16,398 - $80,758	11,232 New	11,232 $38,000

148

162M

150K

29.5K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $408M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Redmond Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Redmond Asset Management, LLC with notifications on news.